Opportunity Information: Apply for W81XWH 13 GWIRP CTDA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness Clinical Trial Development Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on May 14, 2013 and posted on May 14, 2013.
  • Applicants must submit their applications by Sep 18, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $320,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 2 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 13 GWIRP CTDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Gulf War Illness Clinical Trial Development Award (CTDA) is a one-year funding opportunity under the Department of the Army (USAMRAA) Gulf War Illness Research Program (GWIRP) designed to pay for the upfront planning work needed to launch a future Phase II or Phase III clinical trial, including trials of medical devices that fall within FDA device Classes I through III. The program was created because the pre-trial development stage often requires substantial time, coordination, and specialized planning resources, even when the underlying scientific rationale for the trial is already strong. In practical terms, the CTDA is meant to help a team move from a well-supported treatment idea to a fully prepared, review-ready clinical trial package.

A central feature of the CTDA is what it will not fund. It is not a mechanism for collecting new preliminary data, and it is not meant to support pilot studies that generate early signals of efficacy or feasibility. Instead, applicants are expected to come in with the trial rationale already clearly established and backed by appropriate supportive preliminary data. The award is essentially for converting an already-justified intervention concept into an operationally sound clinical trial plan that can withstand scientific review and be positioned for follow-on funding and execution.

The types of activities supported are the nuts-and-bolts components required to stand up a credible Phase II or Phase III effort. This includes developing the clinical protocol and experimental design in detail, building and organizing the research team, setting up collaborations across sites or institutions, and creating training procedures where needed to ensure consistent implementation. It can also cover work related to intellectual property or material property questions, which can become critical when an intervention involves proprietary compounds, devices, or specialized formulations. Because recruitment is often one of the biggest barriers in Gulf War Illness research, the CTDA explicitly supports establishing access to an ill Gulf War veteran population and developing a recruitment strategy that is realistic and compliant with clinical research requirements.

The award also emphasizes operational rigor and readiness for later-stage trials. Supported planning activities include quality control and quality assurance procedures, data collection and data management workflows, and a full data analysis and statistical plan. Applicants can use funds to address practical test article concerns such as purity, formulation, and related readiness issues that could affect dosing, stability, or reproducibility. Safety infrastructure is another key area: the CTDA supports developing a safety monitoring plan and, when applicable, planning the path to FDA regulatory submissions such as an Investigational New Drug (IND) application for drugs/biologics or an Investigational Device Exemption (IDE) for devices. Finally, the award allows for building a transition plan that spells out how the project will move into the next stage, including the resources, partnerships, and steps required to proceed to a full trial or, where relevant, commercialization.

Administratively, this opportunity (Funding Opportunity Number W81XWH-13-GWIRP-CTDA) was offered as a discretionary program using a grant/cooperative agreement instrument type within the Science and Technology / Research and Development category. It listed an expected two awards and an estimated total funding amount of $320,000, with no cost sharing or matching requirement. Eligibility was described as unrestricted, meaning any entity type could apply unless further limited by additional eligibility language in the full announcement. The opportunity was posted May 14, 2013, with a closing date of September 18, 2013 (archived October 18, 2013), and it carried the CFDA number 12.420 (Military Medical Research and Development).

For investigators who are not yet at the point of having a well-supported clinical trial rationale, the announcement points them toward other GWIRP mechanisms instead of the CTDA. Specifically, those needing proof-of-principle or foundational data are directed to the Investigator-Initiated Research Award for basic research on Gulf War Illness, or the Innovative Treatment Evaluation Award for small, early-phase or pilot clinical trials (Phase II or Phase I/II) that evaluate an intervention at an earlier stage than a definitive Phase II/III effort. Contact support for announcement access was provided through the CDMRP Help Desk (301-682-5507).

FAQs: DoD Gulf War Illness Clinical Trial Development Award (CTDA)

What is the DoD Gulf War Illness Clinical Trial Development Award (CTDA)?

The CTDA is a one-year funding opportunity under the Department of the Army (USAMRAA) Gulf War Illness Research Program (GWIRP) intended to fund upfront planning and development work needed to launch a future Phase II or Phase III clinical trial, including eligible medical device trials (FDA device Classes I through III).

What is the main purpose of this award?

The award is designed to support the practical, operational planning required to move from a well-supported treatment concept to a complete, review-ready clinical trial package that can compete for follow-on funding and be positioned for execution.

How long is the CTDA performance period?

The CTDA is described as a one-year funding opportunity.

What kinds of clinical trials is the CTDA meant to prepare?

It is meant to prepare Phase II or Phase III clinical trials, including trials of medical devices that fall within FDA device Classes I through III.

Does CTDA fund the actual Phase II or Phase III clinical trial?

No. The CTDA is intended to pay for the upfront planning work needed to launch a future Phase II or Phase III trial, rather than to conduct the full later-stage trial itself.

What will the CTDA not fund?

The CTDA is not intended to collect new preliminary data and is not meant to support pilot studies aimed at generating early signals of efficacy or feasibility.

Do applicants need preliminary data before applying?

Yes. Applicants are expected to have the trial rationale clearly established and backed by appropriate supportive preliminary data, since the award is not designed to generate that evidence.

If I need proof-of-principle data, is CTDA the right mechanism?

No. The announcement directs investigators who still need foundational data or proof-of-principle work to other GWIRP mechanisms rather than the CTDA.

Which GWIRP mechanisms are suggested for earlier-stage work?

The announcement points to the Investigator-Initiated Research Award for basic research on Gulf War Illness, and the Innovative Treatment Evaluation Award for small, early-phase or pilot clinical trials (Phase II or Phase I/II) evaluating interventions at an earlier stage than a definitive Phase II/III effort.

What planning activities are supported by CTDA?

Supported activities include detailed clinical protocol development and experimental design; organizing the research team; creating collaborations across sites or institutions; and developing training procedures to ensure consistent implementation.

Does CTDA support multi-site coordination and collaboration setup?

Yes. The opportunity includes building collaborations across sites or institutions as a supported planning activity.

Can CTDA funds be used to develop recruitment strategies?

Yes. Because recruitment is a major barrier in Gulf War Illness research, the CTDA explicitly supports establishing access to an ill Gulf War veteran population and developing a realistic, compliant recruitment strategy.

Does the CTDA cover quality control and quality assurance planning?

Yes. The award supports planning for quality control and quality assurance procedures as part of operational readiness for later-stage trials.

Can applicants use CTDA funding for data management and statistics planning?

Yes. Supported activities include data collection and data management workflows, plus development of a full data analysis and statistical plan.

Does CTDA support planning related to the test article (drug/device/material readiness)?

Yes. The CTDA can support addressing practical test article concerns such as purity, formulation, and other readiness issues that could affect dosing, stability, or reproducibility.

Is safety monitoring planning included?

Yes. The award supports development of a safety monitoring plan as part of preparing for a later-stage clinical trial.

Can CTDA funding be used to plan for FDA regulatory submissions?

Yes, when applicable. The opportunity supports planning the path to FDA regulatory submissions such as an Investigational New Drug (IND) application for drugs/biologics or an Investigational Device Exemption (IDE) for devices.

Are intellectual property or material property issues an allowable focus under CTDA?

Yes. The award can cover work related to intellectual property or material property questions, which may be critical for proprietary compounds, devices, or specialized formulations.

Does the CTDA require a plan for what happens after the planning year?

Yes. The award allows for developing a transition plan describing how the project will move into the next stage, including resources, partnerships, and steps needed to proceed to a full trial or, where relevant, commercialization.

What is the Funding Opportunity Number (FON) for this CTDA?

The Funding Opportunity Number listed is W81XWH-13-GWIRP-CTDA.

Which program and organization offered this opportunity?

It was offered under the Department of the Army (USAMRAA) Gulf War Illness Research Program (GWIRP).

How many awards were expected and what was the estimated total funding?

The opportunity listed an expected two awards and an estimated total funding amount of $320,000.

Is cost sharing or matching required?

No. The opportunity states there was no cost sharing or matching requirement.

What was the instrument type for this funding opportunity?

It was offered using a grant/cooperative agreement instrument type.

How was eligibility described?

Eligibility was described as unrestricted, meaning any entity type could apply unless further limited by additional eligibility language in the full announcement.

When was the opportunity posted and when did it close?

It was posted on May 14, 2013, with a closing date of September 18, 2013. It was archived on October 18, 2013.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 12.420 (Military Medical Research and Development).

Where could applicants get help accessing the announcement?

Contact support for announcement access was provided through the CDMRP Help Desk at 301-682-5507.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Region 6 Aquatic Invasive Species

Previous opportunity: Cooperative Agreements for State sponsored Youth Suicide Prevention and Early Intervention (Short Title State and Tribal Youth Suicide Prevention Grants)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 13 GWIRP CTDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 13 GWIRP CTDA) also looked into and applied for these:

Funding Opportunity
Cooperative Ecosystem Studies Unit, Colorado Plateau CESU Apply for G13AS00035

Funding Number: G13AS00035
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Gulf War Illness Investigator Initiated Research Award Apply for W81XWH 13 GWIRP IIRA

Funding Number: W81XWH 13 GWIRP IIRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Life History Diversity of Delta Smelt from the Otolith Analyses of the Spring Kodiak Trawl (SKT) (2005 2006 and 2010 2011 year classes) Apply for R13AS20022

Funding Number: R13AS20022
Agency: Bureau of Reclamation Mid Pacific Region
Category: Science and Technology and other Research and Development
Funding Amount: $227,500
Collaborative Research in Support of GOAmazon Campaign Science Apply for DE FOA 0000919

Funding Number: DE FOA 0000919
Agency: Office of Science
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Great Plains CESU Apply for G13AS00046

Funding Number: G13AS00046
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
GAP ANALYSIS PROGRAM PAD US STATE GRANTS Apply for G13AS00045

Funding Number: G13AS00045
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Californian CESU Apply for G13AS00048

Funding Number: G13AS00048
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Gulf Coast CESU Apply for G13AS00050

Funding Number: G13AS00050
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
National Strategy for Trusted Identities in Cyberspace (NSTIC) Cooperative Agreement Program for the Evaluation of Pilots Using Trusted Online Credentials for Accessing Government Services Apply for 2013 NIST NSTIC 03

Funding Number: 2013 NIST NSTIC 03
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Pacific Northwest CESU Apply for G13AS00049

Funding Number: G13AS00049
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Californian CESU Apply for G13AS00047

Funding Number: G13AS00047
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
NASA SPACE TECHNOLOGY MISSION DIRECTORATE NASA INNOVATIVE ADVANCED CONCEPTS PHASE II STUDIES NASA RESEARCH ANNOUNCEMENT 2013 Apply for NNH13ZUA003N

Funding Number: NNH13ZUA003N
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
BROAD AGENCY ANNOUNCEMENT (BAA) FOR RESEARCH INITIATIVES AT THE NAVAL POSTGRADUATE SCHOOL Apply for NPS BAA 13 004

Funding Number: NPS BAA 13 004
Agency: Naval Supply Systems Command
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Peer Reviewed Cancer Idea Award with Special Focus Apply for W81XWH 13 PRCRP IA

Funding Number: W81XWH 13 PRCRP IA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Peer Reviewed Cancer Career Development Award Apply for W81XWH 13 PRCRP CDA

Funding Number: W81XWH 13 PRCRP CDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Lung Cancer Idea Development Award Apply for W81XWH 13 LCRP IDA

Funding Number: W81XWH 13 LCRP IDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Lung Cancer Career Development Award Apply for W81XWH 13 LCRP CDA

Funding Number: W81XWH 13 LCRP CDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Lung Cancer Clinical Exploration Award Apply for W81XWH 13 LCRP CEA

Funding Number: W81XWH 13 LCRP CEA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Department of Defense (DoD) Research and Education Program for Historically Black Colleges and Universities and Minority Serving Institutions (HBCU/MI) Equipment/Instrumentation Apply for W911NF 13 R 0008

Funding Number: W911NF 13 R 0008
Agency: Dept of the Army Materiel Command
Category: Science and Technology and other Research and Development
Funding Amount: $500,000
JFSP Apply for L13AS00094

Funding Number: L13AS00094
Agency: Bureau of Land Management
Category: Science and Technology and other Research and Development
Funding Amount: $299,313

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 GWIRP CTDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.